Mindfulness may help curb drug relapse, small study suggests
NCT ID NCT07161986
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study tested a mindfulness-based program (MBS) against standard care in 130 adults recovering from polydrug addiction. The goal was to see if MBS could reduce cravings and relapse risk. Researchers also looked at improvements in emotional control, mood, and motivation. The results could point to a supportive, non-drug strategy for staying sober.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mindfulness-based Sobriety (MBS) program
- What this could lead to
- If effective, this approach could offer a practical, drug-free way to help people with polydrug addiction manage cravings and lower their risk of relapse.
- What could go wrong
- This is a small, completed trial with 130 participants, so results may not apply to everyone. The intervention is behavioral, so benefits depend heavily on individual adherence and motivation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
130 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals resided in Drug rehabilitations center with polysubstance use diagnosed particularly with illicit drug use. * Age would be from 18 to 85 years * Must include Patients after detox and withdrawal symptoms. Exclusion Criteria: • Individuals with any form of physical or intellectual disability will not be eligible to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Drug addiction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Save Life Foundation
Abbottābād, Khyber Pakhtunkhwa, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for pregnant women battling opioid addiction: monthly shot vs daily pill
- Exercise program shows promise for drug recovery fitness
- Opioid treatment in pregnancy: which form is safer for Baby's brain?
- New study looks inside the womb to see how opioid medications impact unborn babies
- Peer support could boost opioid treatment in rural areas
- Brain training task may reveal why opioid addiction is so hard to beat